Improving clinical trials: Unlock the power of productivity through protocol design

Fortrea’s Dr. Barbara Gillespie co-authors pivotal paper rethinking membranous nephropathy trials in the anti-PLA2R era

ARVO 2025: Advancing ophthalmology research through innovation and collaboration

Fortrea oncology: Large enough to serve in the UK, engaged enough to care

Over the past decade, there has been remarkable progress in oncology, driven by a deeper understanding of cancer biology and the integration of cutting-edge technologies.

Precision Oncology

Diagnostic Center of Excellence Team

Driving change in nephrology: PARASOL project leads to FDA acceptance of proteinuria